Neonc Technologies Holdings (NTHI) Total Liabilities (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Total Liabilities of $16.6 million for Q1 2026, up 96.18% year-over-year from $8.4 million in Q1 2025, and down 18.54% quarter-over-quarter from $20.3 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Total Liabilities (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Total Liabilities for 3 consecutive years, with $16.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 96.18% year-over-year to $16.6 million; the TTM figure through Mar 2026 stood at $16.6 million (up 96.18% YoY), while the FY2025 annual figure was $20.3 million, up 127.87% from the prior year.
- Total Liabilities declined to $16.6 million in Q1 2026 per NTHI's latest filing, from $20.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $20.3 million in Q4 2025 and bottomed at $8.4 million in Q1 2025.
- Historically, Total Liabilities has averaged $14.2 million across 3 years, with a median of $15.4 million in 2025.
- Annual changes were most pronounced in 2025 — Total Liabilities soared 127.87% — and 2026, when it surged 96.18%.
- Neonc Technologies Holdings' Total Liabilities stood at $8.9 million in 2024, then jumped by 127.87% to $20.3 million in 2025, then decreased by 18.54% to $16.6 million in 2026.
- Business Quant data shows NTHI's Total Liabilities at $16.6 million in Q1 2026, $20.3 million in Q4 2025, and $15.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 23.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.76 Mn |
| Mar 31, 2026 | 16.56 Mn |
| Dec 31, 2025 | 20.33 Mn |
| Sep 30, 2025 | 15.90 Mn |
| Jun 30, 2025 | 14.80 Mn |
| Mar 31, 2025 | 8.44 Mn |
| Dec 31, 2024 | 8.92 Mn |